News

Scientists, clinicians and entrepreneurs shared the latest innovations and initiatives in the rapidly evolving movement to make health care more personal, predictive and preventive at the Precision Medicine World Conference (PMWC) in January. UCSF Speakers at Precision Medicine World Conference UCSF

Choosing among cancer treatments increasingly involves determining whether tumor cells harbor specific, mutated “oncogenes” that drive abnormal growth and that may also be especially vulnerable or resistant to particular drugs. But according to a new study led by UCSF researchers, in the case of the

Last year, UCSF launched the Molecular Oncology Initiative (MOI) to integrate molecular information found in most cancer types with the ever increasing number of therapeutics being developed in translational research and clinical practice. The UCSF Molecular Tumor Board (MTB), a group of experts

Scalp cooling can lessen some chemotherapy-induced hair loss – one of the most devastating hallmarks of cancer – in certain breast cancer patients, according to a new multicenter study from UC San Francisco, Weill Cornell Medicine and three other medical centers. A majority of the study’s patients

Fifteen UC San Francisco faculty members have been named to the first cohort of Chan Zuckerberg Biohub Investigators. The CZ Biohub is an independent nonprofit research organization formed as a collaboration between UCSF, UC Berkeley and Stanford University with the goal of inventing new tools to

A new study led by researchers at UC San Francisco and Kaiser Permanente has identified genetic predictors of normal prostate-specific antigen (PSA) levels in healthy men, which could be used to improve the accuracy of PSA-based prostate cancer screening tests. Until recently, PSA tests for prostate

Women whose breasts are composed largely of glandular tissue, rather than fat, have an amplified risk of breast cancer, which exceeds the impact of other widely known risks on a population level, including family history of the disease, personal history of benign lesions and first full-term